comparemela.com

Latest Breaking News On - Gynecologic oncology laboratory at brigham - Page 1 : comparemela.com

Aspira Women s Health Sees Poster on its miRNA-based Ovarian Cancer Test Presented at the AACR Special Conference in Cancer Research -October 25, 2023 at 08:01 am EDT

AUSTIN, Texas, Oct. 25, 2023 Aspira Women’s Health Inc. , a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gynecologic.

United statesNew yorkDana farber cancer instituteNicole sandfordMonique kosseKevin eliasProviders of the aspira women healthAspira women healthLifesci advisorsAspira women health incCompany ovasuiteGlobenewswire incGynecologic oncology laboratory at brighamDrug administrationHealth incCancer research

Aspira Women s Health, Inc Announces an Agreement for the Development and Commercialization of an Early-Detection Test for Identification of Ovarian Cancer Nasdaq:AWH

AUSTIN, Texas, March 25, 2021 (GLOBE NEWSWIRE) Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today.

United statesElena ratnerAshleyr robinsonWojciech fendlerLesley northropDipanjan chowdhuryKevin eliasAspira women healthLifesci advisorsAspira women health incDivision of radiationTranslational medicine at aspira women healthUniversity lodzClinical divisionGynecologic oncology laboratory at brighamYale university school of medicine

vimarsana © 2020. All Rights Reserved.